相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes
Jay A. Spencer et al.
VACCINE (2021)
Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein?derived peptides
Michelle P. Aranha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study
Elodie Pastural et al.
VACCINE (2020)
Update on group A streptococcal vaccine development
James B. Dale et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2020)
The American Heart Association's Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association
Andrea Beaton et al.
CIRCULATION (2020)
P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine
Imen Ayadi et al.
FRONTIERS IN IMMUNOLOGY (2020)
A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes
Sarrah Boukthir et al.
PLOS ONE (2020)
Decoding the molecular epidemiology of group A streptococcus - an Indian perspective
Tintu Abraham et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease
Philip M. Giffard et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection
Chiuan Yee Leow et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2019)
Variation, Indispensability, and Masking in the M protein
Partho Ghosh
TRENDS IN MICROBIOLOGY (2018)
Biophysical and immunological characterization of the ESX-4 system ESAT-6 family proteins Rv3444c and Rv3445c from Mycobacterium tuberculosis H37Rv
Himanshu Pandey et al.
TUBERCULOSIS (2018)
Applying Unique Molecular Identifiers in Next Generation Sequencing Reveals a Constrained Viral Quasispecies Evolution under Cross-Reactive Antibody Pressure Targeting Long Alpha Helix of Hemagglutinin
Nastasja C. Hauck et al.
VIRUSES-BASEL (2018)
Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Streptococcus pyogenes
Sanaz Salehi et al.
MSPHERE (2018)
Structure-based design of broadly protective group a streptococcal M protein-based vaccines
James B. Dale et al.
VACCINE (2017)
Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity
Hannah R. Frost et al.
CLINICAL INFECTIOUS DISEASES (2017)
Conserved patterns hidden within group A Streptococcus M protein hypervariability recognize human C4b-binding protein
Cosmo Z. Buffalo et al.
NATURE MICROBIOLOGY (2016)
Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors
David Ermert et al.
PLOS PATHOGENS (2015)
A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development
Martina Sanderson-Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
James B. Dale et al.
VACCINE (2011)
The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker
David Metzgar et al.
VIRULENCE (2011)
The streptococcal M protein: a highly versatile molecule
Pierre R. Smeesters et al.
TRENDS IN MICROBIOLOGY (2010)
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes
Thomas A. Penfound et al.
VACCINE (2010)
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development
Andrew C. Steer et al.
LANCET INFECTIOUS DISEASES (2009)
Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes
C Sandin et al.
MOLECULAR MICROBIOLOGY (2006)
Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers
SA McNeil et al.
CLINICAL INFECTIOUS DISEASES (2005)
Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections
MA Hall et al.
INFECTION AND IMMUNITY (2004)
Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults - Phase 1 trial
KL Kotloff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein
F Carlsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Molecular basis of group A streptococcal virulence
AL Bisno et al.
LANCET INFECTIOUS DISEASES (2003)
An HMM model for coiled-coil domains and a comparison with PSSM-based predictions
M Delorenzi et al.
BIOINFORMATICS (2002)
SOCKET: A program for identifying and analysing coiled-coil motifs within protein structures
J Walshaw et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
DE Briles et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
